GENE THERAPY PROJECTS

Pubblicazioni Scientifiche

• 1999-12-03 AIDS

  Recovery of haematopoietic abnormalities in HIV-1 infected patients treated with HAART

• 1997-11-01 BLOOD

  Successful reconstitution of human hematopoiesis in the SCID-hu mouse by genetically modified, highly enriched progenitors isolated from fetal liver

• 1998-07-01 BONE MARROW TRANSPLANTATION

  Immuno responses of cord blood cells

• 1997-03-01 DIABETES CARE

  Cancer arising after pancreas and/or kidney transplantation in a series of 99 diabetic patients

• 1997-03-01 EUROPEAN JOURNAL OF IMMUNOLOGY

  Multiple sites of post-activation CD8(+) T cell disposal

• 1997-04-01 EXPERIMENTAL HEMATOLOGY

  Colony-forming cells expressing high levels of CD34 are the main targets for granulocyte colony-stimulating factor and macrophage colony-stimulating factor in the human fetal liver

• 1997-06-01 GENE THERAPY

  Novel retroviral packaging cell lines: Complementary tropisms and improved vector production for efficient gene transfer

• 1997-10-01 GENE THERAPY

  IFN-gamma gene transfer restores HLA-class I expression and MAGE-3 antigen presentation to CTL in HLA-deficient small cell lung cancer

• 1999-06-11 JOURNAL OF CHROMATOGRAPHY B

  High-performance liquid chromatographic purification and capillary electrophoresis quantification of the chemokine stromal cell-derived factor-1

• 1997-06-15 JOURNAL OF IMMUNOLOGY

  Induction of human T helper cell type 1 differentiation results in loss of IFN-gamma receptor beta-chain expression

• 1997-09-01 JOURNAL OF IMMUNOLOGY

  Functional heterogeneity of HLA-A*02 subtypes revealed by presentation of a MAGE-3-encoded peptide to cytotoxic T cell clones

• 1997-03-01 MOLECULAR AND CELLULAR BIOLOGY

  Interplay of the E box, the cyclic AMP response element, and HTF4/HEB in transcriptional regulation of the neurospecific, neurotrophin-inducible vgf gene

• 1998-10-01 NATURE

  The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

• 1998-11-15 TRANSPLANTATION

  Interleukin-10 dose-dependent regulation of CD4+ and CD8+ T cell-mediated graft-versus-host disease